May 9th 2025
Poor API quality may often lead to delays in production and a shortage of supply.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Science-Based Technical Report Being Developed to Ensure Effective Use of Blow-Fill-Seal Technology
October 23rd 2013The Parenteral Drug Association has established a task force to develop a peer- and regulatory agency-reviewed Technical Report that will serve as a science-based industry reference document.
Sterile, Automated Sampling Enabling PAT for Biopharmaceutical Manufacturing
October 9th 2013Pfizer, Eli Lilly, and several other pharmaceutical companies are participating in the development of automated sampling technology and associated software that improve process control and reduce development times in biopharmaceutical manufacturing.